Although CEA and CA19-9 were used as markers of gastrointestinal malignancies (Bagaria et al., 2013; Gao et al., 2018; Jia et al., 2019), in our study, the serum levels of CEA and CA19-9 in GC patients without BM did not increase significantly. This evidence concerns the gene CEACAM5 and gastric cancer.